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Abstract
Background: Multiple changes are made to older patients’ medicines during hospital 
admission, which can sometimes cause confusion and anxiety. This results in prob-
lems with post-discharge medicines management, for example medicines taken in-
correctly, which can lead to harm, hospital readmission and reduced quality of life.
Aim: To explore the experiences of older patients and their family carers as they en-
acted post-discharge medicines management.
Design: Semi-structured interviews took place in participants’ homes, approximately 
two weeks after hospital discharge. Data analysis used the Framework method.
Setting and participants: Recruitment took place during admission to one of two 
large teaching hospitals in North England. Twenty-seven participants aged 75 plus 
who lived with long-term conditions and polypharmacy, and nine family carers, were 
interviewed.
Findings: Three core themes emerged: impact of the transition, safety strategies and 
medicines management role. Conversations between participants and health-care pro-
fessionals about medicines changes often lacked detail, which disrupted some partici-
pants’ knowledge and medicines management capabilities. Participants used multiple 
strategies to support post-discharge medicines management, such as creating admin-
istration checklists, seeking advice or supporting primary care through prompts to en-
sure medicines were supplied on time. The level to which they engaged with these 
activities varied.
Discussion and conclusion: Participants experienced gaps in their post-discharge med-
icines management, which they had to bridge through implementing their own strate-
gies or by enlisting support from others. Areas for improvement were identified, mainly 
through better communication about medicines changes and wider involvement of pa-
tients and family carers in their medicines-related care during the hospital-to-home 
transition.
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1  | INTRODUC TION
Reducing avoidable medicines-related harm is a global health chal-
lenge, and the World Health Organization has called for its reduction 
to be a priority.1 Certain clinical situations are more likely to result 
in problems with medicines. Transitions in care, where patients are 
handed over from one clinician to another, for example at hospital dis-
charge, are high risk.2 It is estimated that up to 70% of patients expe-
rience unintended changes to their medicines at hospital discharge.3 
These medication errors can result in significant harm for patients and 
a subsequent cost to the health-care service.4-6 Older patients are 
particularly at risk because they often take multiple medicines for a 
variety of conditions, sometimes involving different care providers.7 
Approximately 37% of older people over the age of 65 years are con-
sidered to be at risk of medicines-related harm in the eight weeks fol-
lowing hospital discharge.8
Previously, research has sought to identify the types of medi-
cines-related problems and harm that older patients experience in 
the post-discharge phase.9,10 Problems obtaining medicines sup-
ply, with taking medicines and the effects of poor communication 
and co-ordination are common.6,11,12 Limited research has been 
conducted to elucidate older people's lived experience of post-dis-
charge medicines management, which may help identify gaps in 
current service provision. Those that have, found that most older 
patients were confused or anxious about their post-discharge 
medicines and were often not involved in medicines-related 
decisions.6,12-14
Optimal medicines management (the actions, processes and 
behaviours that determine how medicines are used) promotes 
medicines safety and is thus an important component of effec-
tive post-discharge care.15,16 Previous research has demonstrated 
that interventions provided by health-care professionals (with 
or without patient interaction), such as the reconciliation of pre- 
and post-discharge medicines regimens, may be effective in re-
ducing negative outcomes such as hospital readmission.9,17-19 
Furthermore, cardiology patients and patients within primary care 
have been shown to perform activities that contribute to post-dis-
charge medicines management 20 and to keep themselves safe.21 
It is currently unknown, however, what strategies, if any, older pa-
tients and their family carers use themselves to support medicines 
management.
This study aimed to address this gap and explore the expe-
riences of older patients and their family carers as they enacted 
post-discharge medicines management, focusing on identifying 
what helps and hinders them. Exploring these factors will help 
identify the current medicines management needs and priorities 




This was a descriptive qualitative study that used semi-structured 
interviews to ascertain the opinions, feelings and perspectives 
of participants. Ethical approval for this study was granted by the 
Yorkshire and Humber, Bradford Leeds Local Research Ethics 
Committee, on 3 July 2018, reference 18/YH/0233.
2.2 | Patient and public involvement in this study
Four older patients and family carers were involved in the conception 
and development of this study. Their involvement has been fully docu-
mented elsewhere.22 Briefly, the group co-designed participant docu-
mentation, data collection tools and wording of the interview topic 
guide with the researcher (JT). They also considered the impact that 
the research could have for participants, such as any burden associated 
with in-depth interviews. We particularly valued their interpretations 
of transcript excerpts, which prompted new lines of analysis.
2.3 | Setting and participants
Participants were recruited during their admission to the older peo-
ple's wards at two large teaching hospitals in the North of England. 
Patients were eligible to take part if they: were aged 75 years or 
over; used five or more medicines; lived with long-term conditions 
(frailty and type 2 diabetes mellitus were used as exemplar condi-
tions in this study); and had a medicines change during their admis-
sion to hospital. Family carers of the participants who helped them 
with their medicines at home were also invited to take part. People 
who could not communicate verbally, lacked capacity or those who 
were discharged to long-term care facilities were excluded as these 
were not our population of interest at this time. This study took 
place between August 2018 and November 2019.
A maximum variation sampling technique 23 was used to ensure 
participants with a range of health-care support needs and charac-
teristics (for example those living independently to those requiring 
local authority support, living in sheltered housing to those isolated) 
were recruited.
2.4 | Data collection
Older patients who met the inclusion criteria were approached by the 
researcher during their hospital stay to provide the study information 
K E Y W O R D S
medication management, medication safety, older people, patient safety, qualitative 
interviews, transitions of care
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leaflet, answer questions and obtain written informed consent. If 
they consented to take part, they were contacted approximately two 
weeks after hospital discharge to reaffirm consent. The researcher 
visited participants in their home and conducted the semi-structured 
interview using a topic guide. The guide was developed from clinical 
experience of the patient/medicine pathway, literature about patient 
experiences, and information gathered from practitioner and patient 
stakeholder conversations. Questions with associated probes and 
prompts explored topics including medication-related interactions 
with health-care professionals or other organizations, self-care strate-
gies and examples of post-discharge medication-related problems (see 
Data S1). Participants were also asked about anything that enhanced 
their experience of medication management since hospital discharge. 
The interviews began with a story-telling element, allowing the partici-
pant to offer an uninterrupted, rich narrative around their experiences 
with medicines since hospital discharge.24 Interviews were audio-re-
corded and transcribed verbatim.
2.5 | Data analysis
Inductive thematic analysis is a method that is widely used to 
identify, interpret and report themes in qualitative data.25 The 
Framework method 26 differs from traditional thematic analysis 
as it involves the creation of an analytical framework that is ap-
plied and used to chart data into a matrix. This allows the data to 
be compared across and within individual participants. This en-
sures the analytical process is much more systematic, auditable 
and comprehensive, as all participants are considered, not just 
dominant ones.27 The analysis of our data followed the Framework 
method as outlined by Ritchie et al.27 Interviews were coded by JT 
and managed in groups of seven to make concurrent data collec-
tion and analysis manageable. BF independently coded a quarter 
of all interviews and held frequent discussions with JT to agree 
thematic development. This also allowed for careful consideration 
of data saturation. Codes obtained from the first seven interviews 
were collated and aggregated inductively into an analytic frame-
work to guide the creation of the matrices. We decided against 
using a deductive approach, where a priori coding frameworks 
are applied to the interview data, so that all important factors 
within the interviews were considered and none overlooked.28 
This analytic plan was reviewed by all authors and adapted to en-
sure that all codes could fit, resulting in the creation of six matri-
ces, recorded using NVivo 11 software. Interview transcripts for 
each participant were re-read, and key issues pertaining to that 
theme of the matrix were summarized. Any ideas or experiences 
within the transcripts that would not fit within the matrix were 
discussed between study authors, and further changes were made 
to the analytic plan as appropriate. This process continued until 
data saturation occurred, with no new ideas or themes emerging. 
The matrices were then individually interrogated to identify the 
key elements within each summary. The detected elements were 
iteratively sorted into categories. Higher level categories became 
themes, and lower level categories became subthemes. The the-
matic analysis was finally refined through discussion with all the 
authors.
3  | FINDINGS
During their hospital admission, 42 patients consented to take 
part in this interview study. Unfortunately, a proportion of these 
participants were readmitted to hospital (n = 2), became too ill 
(n = 4), lost interest (n = 6) or subsequently died (n = 3) before 
an interview could take place. In total, 27 older participants 
(21 female; mean age 84 years), along with nine family carers, 
were interviewed, before data saturation occurred with no new 
codes arising from the transcripts. The majority of participants 
were White British (n = 26) with one participant being of Afro-
Caribbean heritage. Participants requested that their family carer 
be interviewed at the same time as them; therefore, eight inter-
views (one participant involved two family carers) were conducted 
with patient-carer dyads.
All participants had at least one medication change or recom-
mendation made about their medicines (mean 4.6 changes). Some 
returned home with packages of support provided by the local au-
thority (n = 18) to help them recuperate mobility or for homecare 
purposes (see Table 1 for full participant characteristics).
3.1 | Framework analysis
Three thematic areas with eight subthemes (see Figure 1) were 
identified. The core themes were as follows: impact of the transi-
tion, safety strategies and medicines management role. Participants 
described how the nature of their hospital admission, and subse-
quent return home with changes to established medicines regi-
mens, disrupted their medicines management. To mitigate issues, 
participants performed various activities that supported medica-
tion safety. The level to which participants performed these activi-
ties appeared to depend on their relationship with their medicines, 
their health-care professionals and their perceptions of their post-
discharge care. Each theme will be presented in turn, supported by 
verbatim quotes from participants, using pseudonyms to maintain 
confidentiality.
4  | THE IMPAC T OF THE HOSPITAL-TO -
HOME TR ANSITION
The first theme includes two subthemes: disruptions and experi-
encing gaps. Participants described how their transition from the 
hospital disrupted their medicines-related knowledge, routines and 
capabilities. There were gaps, or structural faults in the system, as 
there was no service or process to help participants re-orientate or 
cope with these disruptions.
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4.1 | Disruptions
Following discharge from hospital, participants were unsure which, 
if any, of their medicines had been changed:
'I think some of them have changed but I’m not sure 
which…'. [Nancy, 82]
'Yes, they changed one or two, because I was on aten-
olol when I went in and they stopped that but when I 
came out they didn’t say'. [Charles, 82]
Where participants had managed their own medicines before 
admission, multiple regimen changes disrupted the systems that had 
worked for them beforehand and some found themselves struggling 
with stock management or to administer their doses. Elizabeth (87) re-
ported how she knew all her medicines before admission; however, by 
the time of hospital discharge she no longer knew what she was taking, 
when or why. This greatly impacted on her medicines-taking abilities 
and confidence when she returned home:
'… we’d got all these boxes I said, “I can’t cope with that,” 
you know because I just didn’t know what they were'.
Fluctuating health, post-discharge deterioration and prolonged re-
covery also affected participants’ medicines management capabilities. 
In the early post-discharge phase, they often did not feel well, forgot 
to take their medicines or struggled to access their doses due to lower 
levels of mobility:
''When I got home I were thinking to myself I think 
they’ve let me out too early; I’m not ready, you know, 
because I didn’t feel… I didn’t feel as if I could cope, 
you know, with everything and I was forgetting my 
tablets…'. [William, 79]
4.2 | Experiencing gaps
A lack of quality conversations during hospital admission was 
noticed by most participants. They described how they had not 
known what was happening, perceived clinicians to be withhold-
ing information or felt that medicines had been changed without 
permission:
'I accept when they tell me, what I don’t like is doing 
it behind my back and thinking that an old codger of 
80, he won’t remember what his tablets were; I do'. 
[Robert, 80]
TA B L E  1   Characteristics of participants (n = 27)





≥75 - <85 16 (59%)
≥ 85 - <95 11 (41%)
Mean 84 years
Length of inpatient staya 
0 – <5 days 4 (15%)
≥5 - < 10 days 10 (38%)
≥10 - <15 days 5 (19%)
≥15 - <20 days 3 (12%)
≥ 20 days 4 (15%)
Mean 11 days
Number of medicines changes
0 – <5 18 (66%)











Sheltered accommodation 5 (19%)
Who helps with medicines
No one 6 (22%)
Family 17 (63%)
Adult social services 3 (11%)
Combination of family and social services 1 (4%)
aLength of stay was unknown for one participant. 
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'Nobody explained anything. I didn’t even know they 
took me off the rivaroxaban'. [Winifred, 78]
Conversations at discharge were also limited. For example, Robert 
(80) had his new medicines sent out to him via a taxi, with no one 
speaking to him about this treatment. Others, like James (79), were not 
provided with any explanation despite receiving their medicines on the 
ward; 'I was just given the bag of medication and that [discharge letter]'. 
Family carers reported similar experiences:
'when we got there they'd just gone for the tablets, 
so it's just like yeah, there's your tablets, off you go'. 
[Elaine's (96) daughter]
This left participants and their family carers with unanswered ques-
tions about their conditions, why changes had been made, what they had 
to do once they had returned home or what side effects to anticipate:
'…but you still don’t know why they took her in twice 
and why, you know, she’s had the stopping of the cho-
lesterol and the acid tablet, you used to take two and 
now they’ve changed that just to one'. [Betty’s (85) 
daughter]
'I did say to someone “Has my medicines changed?” 
and they said “We don’t know” but they have 
changed'. [Hazel, 91]
Following discharge, participants encountered issues with: delayed 
supplies, ordering new items, oversupply of things no longer needed 
and incorrect medicines within their multicompartment compliance 
aids. Problems with follow-up and care co-ordination within the com-
munity were also frequent; for example, Shirley (81) described being 
unclear who her follow-up appointments were with, or why she 
needed to attend; Joan (78) was concerned her blood pressure had 
not been reviewed since the hospital had stopped her blood pressure 
medication; and in Eleanora's (83) case, there was a failure to restart 
homecare services.
5  | SAFET Y STR ATEGIES
To mitigate these disruptions, participants proactively developed 
techniques and activities to support post-discharge medicines 
management. These strategies involved adapting pre-admission 
medicines administration routines, reaching in to proactively sup-
port the health-care system and being vigilant.
5.1 | Adaptation
Changes to regular routine, or home environment after hospital dis-
charge, allowed participants to take control and manage their own 
medicines. Routine appeared important for many, and participants 
described how they developed new post-discharge regimens in rela-
tion to their meals or personal daily milestones:
'I’ve started to take my medication different now, dif-
ferent times [...] so I get up about half past six in a 
morning and make myself a cup of coffee, and then 
just wait a bit and take another couple of tablets and 
then I take another one that leaves me two after I’ve 
had my breakfast'. [Betty, 85]
Furthermore, some participants changed the way they per-
formed their often complex medicines-taking behaviours. Doris (88), 
for example, preferred to sit at her armchair and work through her 
discharge paperwork, popping the required tablets into a pot before 
taking them. Enid (81) decided to set her daily medicines out on a 
circular tray, depicting the hours of the day when she preferred to 
take them. Joan (78) used to keep all her medicines in her bedroom, 
but since discharge, she preferred to keep them all together by her 
armchair:
'I keep them in the magazine rack, they’re in a sand-
wich box in magazine rack, so they’re in order, [I] go 
round sort of thing…'. [Joan, 78]
5.2 | Scaffolding
Scaffolding activities involved participants, family carers and in 
some instances clinicians, who proactively provided temporary 
support to the participant or the health-care system.29 For exam-
ple, Betty's (85) and Elaine's (96) daughters acted as conduits for 
information and took the discharge paperwork to the primary care 
practitioner and/or community pharmacist as soon as possible after 
discharge. Alice (92) alerted the community pharmacist that she had 
been discharged so that the medication supply could be restarted. 
Hazel (91) and Dorothy (82) went one step further and took their 
discharge medication supply into the pharmacy to show them what 
their new medicines were:
'They (hospital) gave me some more [medication] to 
take which I take to the chemist and let them know'. 
[Dorothy, 82]
Temporary or impromptu strategies were also used in the early 
post-discharge period to support safe administration of medicines, 
whilst participants were recuperating. Marie's (81) daughter anno-
tated the calendar when doses were due to change, and Mary's (81) 
husband produced checklists to show what medicines should be 
taken and when. James’ (79) daughter helped him to rationalize his 
stock of medicines, and Elizabeth's (87) daughter set out her med-
icines in individual pots, every day, until she was used to the new 
regimen.
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5.3 | Error avoidance
Participants and their family carers carried out activities that 
aimed to prevent medication errors. They sought information and 
took time to study their new medicines in order to grow in confi-
dence with them. They did this by reading medicines information 
leaflets, using the Internet or asking their clinicians for further 
information:
'…because on the lid it says what you’re taking doesn’t 
it, and when you’re taking them? So, we did read that 
to make sure that they were the ones that I should be 
taking'. [Elizabeth, 87]
Participants were also able to anticipate potential gaps in onward 
care from their previous experiences of being in hospital. If they had 
concerns about certain elements of post-discharge care, they then de-
fended against them by asking specific questions to the care team. This 
enabled them to better prepare themselves for post-discharge medi-
cines management:
'Well yeah, ‘cause it’s belt and braces, I needed to 
make sure that they’d got the right you know…[…]… 
That’s why I rang them ‘cause I thought if there’s 
going to be any delay I’ll just go and pick it up myself'. 
[Patricia’s (85) daughter]
'…because many a time I’ve read up where people 
have been given the wrong medication, so to be safe, 
for my peace of mind, nobody else’s, I like to question 
each tablet'. [Marie, 81]
Close stock control also ensured appropriate quantities of 
medicines were available to mitigate against supply issues, such 
as late delivery by the community pharmacy. Mary's (81) husband 
made sure to have at least two months of each medicine in stock. 
Robert (80) and James (79) separated out their stopped medicines 
from the current supplies, intending to return them to the commu-
nity pharmacy. Others, such as Marie (81) and Joan (78), had too 
much stock at home due to oversupply and took active steps to 
reduce or stop this. Hazel (91) proactively returned her old medi-
cines to the community pharmacy immediately after changes had 
been made.
6  | MEDICINES MANAGEMENT ROLE
How participants perceived their role in medicines management 
determined how they enacted safety strategies; how they enacted 
their role was determined by the view of the importance of their 
medicines, the relationship with the primary care provider, and the 
co-ordination of their care.
6.1 | The view of their own role
Participants appeared to assume a range of roles within their post-
discharge medicines management. Some were actively engaged in 
medicines management and wished to be fully informed and in-
volved in decisions about their medicines. They described how they 
were not afraid to tell someone if they were unhappy about issues 
related to their medicines and felt empowered to ask questions of 
health-care professionals:
'If I don’t like something and I don’t see… I want to know 
why not. Like I say, it’s the only way you find out stuff 
is to ask. If you don’t ask, you don’t know'. [Marie, 81]
'Like I asked about the leg; this is my leg not yours, so 
I don’t care what you think about that, if I’m not happy 
about it I will tell you and I will ask you to see your 
superior'. [James, 79]
Other participants, such as Enid (81) and Ruth (90), had lived with their 
condition(s) for a long time, which prompted them to learn about what their 
medicines did and how they worked. They often prioritized certain medi-
cines that were important to them (eg. for heart and blood) and therefore 
could describe fully any associated medicines changes. For these partici-
pants, medicines management required effort and significant daily work:
'But it’s like a job really, if you know what I mean? I know 
it’s silly but it’s like having a job, oh I’ve got to break off 
and do this [my medicines], you know?' [Enid, 81]
Despite having to repeatedly scaffold the system to ensure she 
received her medicines on time, Alice (92) firmly believed that she 
should not have sole responsibility for her medicines; 'I mean I have 
to do it [meds management] all myself you see? And it's not right at my 
age'. Furthermore, a few participants simply could not manage their 
medicines and relied on others, such as formal carers, to administer 
them. This was often due to their feelings of deteriorating memory or 
reduced capability after discharge, such as Margaret (82): 'No I leave it 
[medicines] for the carers…[…]… It's something I won't be doing' and Elsie 
(84): 'No, I couldn't now, no, my brain's not there; half of it is missing'.
Other participants administered their own medicines but did not 
appear concerned about the medicines that they took. Hazel (91) 
had adopted this attitude following her numerous hospital admis-
sions and subsequent changes to her medicines; '…every time I go in 
hospital some doctor or other changes some tablets. I think because they 
change every time you go, just take them, so that's all I do'.
6.2 | Relationships with health-care professionals
Negative relationships with health-care professionals led to a lack of 
trust in clinicians to perform their role, or left the participant feeling 
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that they could not call on them for advice. Some of the participants 
had very strained relationships with their primary care provider, and 
this prompted a lack of engagement with their clinicians and some-
times with their medicines:
'No, no, I’ve never seen him (the General Practitioner 
(GP)). I were thinking about that last night whether to get 
in touch with them again or tell them at clinic on Monday 
and I thought well the best will be to go to clinic because I 
can spend three-quarters of an hour and not get through 
(on the telephone)' [William, 79].
Community pharmacists were sometimes seen as the ‘supplier’ 
or ‘dispenser’ of medicines. Some participants, such as Harry's (90) 
daughter, Patricia's (85) daughter and Robert (80), explained that they 
would not consider asking their pharmacist for advice or information 
beyond this supply function. Those participants who described more 
long-standing, positive relationships trusted their pharmacist to ex-
plain things fully, valued the service that they received and felt well 
looked after. Participants therefore often took steps, such as contact-
ing the pharmacy after discharge, to ensure they were kept up to date 
with discharge information.
6.3 | Perceptions of care co-ordination
Many participants believed that information about their admis-
sion was transferred between the hospital, community pharmacy 
and their primary care provider. Whilst they assumed this was the 
case, they did not know by which processes this might occur. Mary 
(81), for example, firmly believed that follow-up plans were in place, 
and Joan (78) believed that important day-to-day information was 
passed between key individuals within primary care (for example her 
district nurse was passing information to the GP), although they had 
no evidence that this was the case:
'We are expecting to attend a follow up… I know our 
GP will have received a copy of this and that’s it isn’t 
it. Just have to wait and see now'. [Mary, 81]
'…well they (GP) just go by what district nurses tell 
them about this. And I suppose they know and the 
home care as well, everything is written down in that 
book (nurse’s notes kept in the home)…'. [Joan, 78]
Other participants perceived their care as disorganized, bordering 
on chaotic. Some felt that they had to take charge and co-ordinate 
care by themselves, especially since they did not trust the system to 
do what it is supposed to. They were frustrated at needing to contin-
ually follow things up and described the burden that this added. Some 
perceived there to be poor communication between sectors, which led 
them to believe that they must act as conduits:
'I mean it is just that annoying when you have to keep 
ringing and thinking why but it’s not the first time I’ve 
had to go over the medication in [the] doctor’s sur-
gery'. [Elaine’s (96) daughter]
'I said, “They told me it was sent late, say mid-after-
noon. Now they're saying they haven't received it.” …
[…]…So why? Who is telling stories? It took two days 
to get a prescription'. [Betty’s (85) husband]
7  | DISCUSSION
This study aimed to explore the perceptions of older people and 
their carers, about their post-discharge medicines management. We 
found three main themes and eight subthemes describing how a 
hospital stay, followed by transition home with changed medication, 
was experienced as a disruption to knowledge, routine and capabil-
ity. This affected participants’ medicines management, and various 
strategies were used to help support medicines use.
The findings from our analysis add to the body of literature 
about post-discharge medicines management, which spans the 
last ten years.6,9,12-14,16 Deficiencies in medicines conversations 
and information provision at discharge significantly affected par-
ticipants’ abilities to manage their medicines. Knight et al similarly 
concluded that most participants in their study reported little or no 
provision of information about changed medicines, which left them 
feeling disappointed or confused about their discharge medicines.6 
Obtaining an overview of medicines changes has previously been 
found problematic for older people living with frailty in Denmark.13 
Conversations detailing medication changes are valuable, especially 
to older patients who are likely to have multiple changes to their 
regimens throughout their inpatient admission.30 This ensures that 
they understand what has been changed and what they need to do 
differently. This present study, however, has shown that participants 
felt these conversations were often lacking detail, did not answer 
their question or simply did not happen at all.
To work around subsequent medicines-related problems or 
gaps in care, participants described using various strategies and 
techniques, which helped them promote the safe use of post-dis-
charge medicines. Similar strategies have been found in medicines 
management work performed by cardiology patients, where they 
anticipated discrepancies and mitigated their occurrence by facili-
tating communication between care settings.31 Furthermore, re-
search with heart failure patients found similar experiences which 
identified the props, or strategies participants used to overcome 
gaps in the system.32 Experienced carers within our study explained 
how they used pre-prepared lists of questions to ensure that they 
found out the appropriate details that they would need to support 
onward medicines management. This foresight may be beneficial 
since questions often arise after the transition home, when patients 
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and carers resume their on-going care activities and they are un-
sure where to seek answers.31 In this study, most participants and 
their carers attempted to seek information for their unanswered 
questions at a later stage, following discharge. This was challenging 
as care had been handed over to a different clinician in a different 
setting. Research should therefore be conducted to identify how to 
better prepare older patients and their family carers for post-dis-
charge medicines management.
Interestingly, previous work has emphasized that older people 
living with frailty do want to be involved in their care; however, 
it has remained unclear how and to what extent.33 This study 
has demonstrated a range of activities that older patients can 
and do engage with. Current patient safety literature advocates 
the engagement of patients as partners in their care in order to 
overcome threats to safety and to improve patient-centred out-
comes.29,34,35 Furthermore, low levels of patient participation are 
associated with an 8% to 21% higher health-care cost.36 Hence, 
health-care professionals should work together with patients to 
encourage shared decision making. Previous literature, however, 
has identified that patients over 65 years preferred less engage-
ment in their care whilst in hospital 37-39 and less information 
about their medicines.40 Whilst this may be true for some older 
patients, our findings demonstrate a range of preferences for 
engagement, and therefore, the level of need and desire should 
be considered for each individual patient. Furthermore, if med-
icines conversations are not held with patients after discharge, 
medicines may be left without continual review for a long time. 
This also limits the opportunities for the patient to be involved 
in the shared decisionmaking process that should occur regularly 
along with medication reviews. Belcher et al identified three cat-
egories of medicines decision making in the older patient: those 
who do not want to participate; those who cannot; and those 
who can and should participate.41 Parallels can be drawn to the 
current study, where a similar range of roles within medicines 
management behaviours were found. Our analysis, however, 
demonstrated that the roles were not static. Some participants 
were able to escalate their participation to meet the additional 
challenges the disruption to their routines presented, for exam-
ple by implementing safety strategies. Therefore, it must not be 
assumed that patients will always perform one role, and similarly, 
any interaction with the system must identify the current role 
and the desire to move on.42
Willingness to participate is also dependent on the task at 
hand 41 and trust in the health-care professional; 43 therefore, 
careful exploration of what post-discharge medicines manage-
ment involves for the patient should be performed as part of the 
hospital discharge process. A study showed that 90% of patients 
(n = 100) were willing to trial deprescribing if their doctor thought 
it appropriate.43 Eassey et al argue that it is the responsibility of 
health-care professionals to assess their patient's preference for 
this level of engagement; however, there are limited validated 
strategies available to do this.44 Flink et al further demonstrated 
that health-care professionals are key to encouraging the engage-
ment of patients and family carers, most often through supportive 
conversations.38 Within the present study, conversations about 
medicines, beyond ascertaining a medicines history at admission, 
were not perceived to have occurred.
Involving patients throughout their journey in order to resolve 
any knowledge and skill deficits appears to be one way to ensure that 
patients, and their family carers, have the tools to enact medicines 
management. Other interventions, such as patient education and 
services to reconcile old and new medicines, have been proposed to 
better help patients prepare for discharge and to support successful 
hospital-to-home transitions.17-19 A recent systematic review has fur-
ther illustrated the importance of communication and engagement 
with patients across the transition, rather than just at discharge, 
with components describing self-management activities being most 
effective.45 Whilst it is clear that patients and their carers are able 
to do certain tasks to promote medicines safety, it is unclear what 
discrete activities contribute to the self-management of medicines. 
Furthermore, there is a lack of evidence as to what behaviours con-
tribute to successful self-management and how clinicians can coach 
patients, at the various levels of engagement, towards this. A use-
ful model for further exploration in this context is that of ‘mindful 
organization’.46 Patients can contribute to medicines safety through: 
applying knowledge about medicines risks, communicating with 
health-care professionals, using artefacts, such as medicines leaflets 
and labels, and recognizing levels of trust.
7.1 | Implications for practice
This study demonstrates that opportunities to engage with older 
patients as a resource for successful post-discharge medicines man-
agement are missed, for example, through appropriate conversa-
tions throughout the hospital stay (including discharge) and shared 
decision making. In order to promote wider involvement of older 
people in their medicines care, established services (such as struc-
tured medication reviews or advice about new medicines) or support 
for patients should be visible, accessible and suitable. For example, 
current services within England that support post-discharge medi-
cines management often rely on the patient to proactively visit their 
community pharmacy or on a pharmacy team to identify which pa-
tients require support and to contact them via telephone as part of 
their already busy workload.47
Some progress has been made however, with a new UK discharge 
service announced by the Department of Health and Social Care.48 
This appears to focus on the transfer of information from the hos-
pital to community pharmacy, similar to services already available in 
some places.49,50 Whilst it is unknown what is available within this 
service, it currently does not appear to integrate the patient within 
it. Given the lack of engagement and involvement highlighted by this 
study, it would be beneficial to rethink future services and ensure 
they are truly person-centred.
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7.2 | Methodological considerations
This study involved a moderate sample size, which allowed the deep 
exploration of rich and varied experiences. The sample was limited 
in its ethnic diversity and does not represent the wider population of 
the UK. It is therefore unclear whether the findings are transferra-
ble to other patient groups and to the population as a whole. Whilst 
made up of predominantly White British participants, we achieved 
the recruitment of a varied sample with regard to medicines manage-
ment needs.
The first author conducted the framework analysis, supervised 
by BF who read and independently coded 25% of transcripts. All 
authors were involved in the development and refinement of the 
final thematic areas. Reflexivity is presented so that the lens through 
which the analysis was observed is clear. JT is an older people's phar-
macist, who may have influenced interview conduct and subsequent 
analysis; however, the Framework method26,27 ensured that we re-
mained true to the content of the interviews. Interviews were con-
ducted two weeks after hospital discharge, which may have affected 
participant's recall of events.
8  | CONCLUSION
This study has provided an in-depth exploration of older pa-
tient's experiences of post-discharge medicines management. 
Participants faced significant disruptions to their medicines 
knowledge and capabilities, which impacted on their manage-
ment abilities once home. They also perceived gaps in their on-
ward care, which some participants were able to mitigate against 
by developing their own strategies to support medication safety. 
Opportunities exist to involve and engage older patients living 
with frailty and, where appropriate, their family carers, during 
their hospital stay and in the post-discharge period, to ensure ef-
fective medicines management.
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